Zwisler Laboratorium GmbH

https://www.zwisler-laboratorium.com

Cormica, a global leader in life sciences testing and consulting, announced in January 2025, it has completed the acquisition of Zwisler Laboratorium, a premier provider of laboratory services headquartered in Reichenau, Germany. This landmark acquisition marks Cormica’s first entry into the German market, a key milestone in its strategy to expand its European footprint. The move underlines Cormica’s commitment to becoming a leading operator in high-growth European markets, with plans to explore additional opportunities for expansion in Germany. Founded in 2001, Zwisler Laboratorium operates from a modern facility in southern Germany and delivers tailored services to pharmaceutical, biotech, packaging and medical device industries across Europe. The laboratory specialises in in-vitro pyrogen test, IFU, reprocessing validation, environmental monitoring, microbiological integrity tests, and bespoke consulting services to support clients in meeting stringent regulatory requirements. It has also developed cutting-edge in-vitro testing options to reduce in-vivo testing, further advancing its commitment to innovation. Cormica, backed by Limerston Capital, operates leading laboratory facilities in the UK and the US, offering a broad spectrum of testing services including medical device proof-of-concept testing, in-vitro validation, pharmaceutical and device stability studies and batch release testing. Its services extend to GxP compliance, biocompatibility, sterility, broader microbiological testing, and physical performance testing, ensuring thorough support for clients. With a rapidly growing reputation as a global leader, Cormica is committed to helping life science manufacturers bring lifesaving medical technologies to market more quickly, more safely, and more efficiently. The acquisition of Zwisler builds on this mission, bringing German-based microbiological expertise into Cormica’s portfolio and providing clients with access to an expanded range of services. The move strengthens Cormica’s ability to support its customers in navigating the complex regulatory environments of Europe and beyond. *

	Start	2010-01-01 renamed
	Group	Cormica (Group)
	Predecessor	Qualis Laboratorium GmbH
	Industry	laboratory services
	Industry 2	medical device
	Person	Zwisler, Walter (Zwisler Laboratorium 202501 Managing Director)

	Region	Konstanz (Constance)
	Country	Germany
	Street	9 Am Wollmatinger Ried
	City	78479 Reichenau
	Tel	+49-7531-9911-00
		Address record changed: 2025-01-26

Basic data	Employees	n. a.

		* Document for »About Section«: Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH".

		Record changed: 2025-03-16

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Cormica (Group)

[1] Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)